Postigo-Fernandez, J., Firdessa-Fite, R., & Creusot, R. J. (2022). Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes. Proceedings of the National Academy of Sciences, 119(15). https://doi.org/10.1073/pnas.2110987119

Nauman, G., Danzl, N. M., Lee, J., Borsotti, C., Madley, R., Fu, J., Hölzl, M. A., Dahmani, A., Dorronsoro Gonzalez, A., Chavez, É., Campbell, S. R., Yang, S., Satwani, P., Liu, K., & Sykes, M. (2022). Defects in Long-Term APC Repopulation Ability of Adult Human Bone Marrow Hematopoietic Stem Cells (HSCs) Compared with Fetal Liver HSCs. The Journal of Immunology, 208(7), 1652–1663. https://doi.org/10.4049/jimmunol.2100966

Merola, J., Shamim, A., & Weiner, J. (2022). Update on immunosuppressive strategies in intestinal transplantation. Current Opinion in Organ Transplantation, 27(2), 119–125. https://doi.org/10.1097/mot.0000000000000958

Huang, J. J., Gaines, S. B., Amezcua, M. L., Lubell, T. R., Dayan, P. S., Dale, M., Boneparth, A. D., Hicar, M. D., Winchester, R., & Gorelik, M. (2022). Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome. Journal of Allergy and Clinical Immunology, 149(3), 912–922. https://doi.org/10.1016/j.jaci.2021.10.015

Bansal, R., Park, H., Taborda, C. C., Gordillo, C., Mapara, M. Y., Assal, A., Uhlemann, A.-C., & Reshef, R. (2022). Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(3), 135–144. https://doi.org/10.1016/j.jtct.2021.12.015

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175

Menghrajani, K., Gomez-Arteaga, A., Madero-Marroquin, R., Zhang, M.-J., Bo-Subait, K., Sanchez, J., Wang, H.-L., Aljurf, M., Assal, A., Bacher, V. U., Badawy, S. M., Bejanyan, N., Bhatt, V. R., Bredeson, C., Byrne, M., Castillo, P., Cerny, J., Chhabra, S., Ciurea, S. O., … Saber, W. (2022). Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Advances, 6(3), 828–847. https://doi.org/10.1182/bloodadvances.2021004881

Lopez-Bujanda, Z. A., Haffner, M. C., Chaimowitz, M. G., Chowdhury, N., Venturini, N. J., Patel, R. A., Obradovic, A., Hansen, C. S., Jacków, J., Maynard, J. P., Sfanos, K. S., Abate-Shen, C., Bieberich, C. J., Hurley, P. J., Selby, M. J., Korman, A. J., Christiano, A. M., De Marzo, A. M., & Drake, C. G. (2021). Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer, 2(8), 803–818. https://doi.org/10.1038/s43018-021-00227-3

Lombardo, K. A., Obradovic, A., Singh, A. K., Liu, J. L., Joice, G., Kates, M., Bishai, W., McConkey, D., Chaux, A., Eich, M., Rezaei, M. K., Netto, G. J., Drake, C. G., Tran, P., Matoso, A., & Bivalacqua, T. J. (2021). BCG invokes superior STING‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer. The Journal of Pathology, 256(2), 223–234. Portico. https://doi.org/10.1002/path.5830

Hawley, J. E., Pan, S., Kandadi, H., Chaimowitz, M. G., Sheikh, N., & Drake, C. G. (2021). Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T. JNCI: Journal of the National Cancer Institute, 114(2), 314–317. https://doi.org/10.1093/jnci/djab145

Jain, R., Habal, M. V., Clerkin, K. J., Latif, F., Restaino, S. W., Zorn, E., Takeda, K., Naka, Y., Yuzefpolskaya, M., Farr, M. A., Colombo, P. C., Sayer, G. T., Uriel, N., & Topkara, V. K. (2021). De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients. ASAIO Journal, 68(2), 226–232. https://doi.org/10.1097/mat.0000000000001451

Mor, A., & Strazza, M. (2022). Bridging the Gap: Connecting the Mechanisms of Immune-Related Adverse Events and Autoimmunity Through PD-1. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.790386

Macedo, R., Pasin, C., Ganetsky, A., Harle, D., Wang, X. K., Belay, K., Richman, L. P., Huffman, A. P., Vonderheide, R. H., Yates, A. J., Porter, D. L., Wang, Y., Zhang, Y., & Reshef, R. (2022). Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature. Transplantation and Cellular Therapy, 28(1), 18.e1-18.e10. https://doi.org/10.1016/j.jtct.2021.09.017

Wu, Y., Fu, J., Wang, H., & Yu, X.-Z. (2021). Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.778996

Khosravi-Maharlooei, M., Madley, R., Borsotti, C., Ferreira, L. M. R., Sharp, R. C., Brehm, M. A., Greiner, D. L., Parent, A. V., Anderson, M. S., Sykes, M., & Creusot, R. J. (2022). Modeling human T1D-associated autoimmune processes. Molecular Metabolism, 56, 101417. https://doi.org/10.1016/j.molmet.2021.101417

Thapa, P., Guyer, R. S., Yang, A. Y., Parks, C. A., Brusko, T. M., Brusko, M., Connors, T. J., & Farber, D. L. (2021). Infant T cells are developmentally adapted for robust lung immune responses through enhanced T cell receptor signaling. Science Immunology, 6(66). https://doi.org/10.1126/sciimmunol.abj0789

Fu, J., & Sykes, M. (2022). Emerging Concepts of Tissue-resident Memory T Cells in Transplantation. Transplantation, 106(6), 1132–1142. https://doi.org/10.1097/tp.0000000000004000

Vecchione, A., Jofra, T., Gerosa, J., Shankwitz, K., Di Fonte, R., Galvani, G., Ippolito, E., Cicalese, M. P., Schultz, A. R., Seay, H. R., Favellato, M., Milardi, G., Stabilini, A., Ragogna, F., Grogan, P., Bianconi, E., Laurenzi, A., Caretto, A., Nano, R., … Fousteri, G. (2021). Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes. Diabetes, 70(12), 2892–2902. https://doi.org/10.2337/db21-0091

Strazza, M., Azoulay-Alfaguter, I., Peled, M., Adam, K., & Mor, A. (2021). Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells. Communications Biology, 4(1). https://doi.org/10.1038/s42003-021-02225-8

Cordero, H., King, R. G., Dogra, P., Dufeu, C., See, S. B., Chong, A. M., Uhlemann, A.-C., Ho, S.-H., Kalfa, D. M., Bacha, E. A., Kearney, J. F., & Zorn, E. (2021). Intrathymic differentiation of natural antibody-producing plasma cells in human neonates. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-26069-2

Miron, M., Meng, W., Rosenfeld, A. M., Dvorkin, S., Poon, M. M. L., Lam, N., Kumar, B. V., Louzoun, Y., Luning Prak, E. T., & Farber, D. L. (2021). Maintenance of the human memory T cell repertoire by subset and tissue site. Genome Medicine, 13(1). https://doi.org/10.1186/s13073-021-00918-7

Pasin, C., Moy, R. H., Reshef, R., & Yates, A. J. (2021). Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-82562-0

Teng, F., Tachó-Piñot, R., Sung, B., Farber, D. L., Worgall, S., Hammad, H., Lambrecht, B. N., Hepworth, M. R., & Sonnenberg, G. F. (2021). ILC3s control airway inflammation by limiting T cell responses to allergens and microbes. Cell Reports, 37(8), 110051. https://doi.org/10.1016/j.celrep.2021.110051

Fu, J., Khosravi-Maharlooei, M., & Sykes, M. (2021). High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.777756

Li, S., Fu, J., Yang, J., Ma, H., Mapara, M. Y., Marcireau, C., & Lentzsch, S. (2021). MAP4K2 Silencing Overcomes IMiDs-Resistance in Multiple Myeloma. Blood, 138(Supplement 1), 2662–2662. https://doi.org/10.1182/blood-2021-151844

Park, J. H., Nikiforow, S., Kim, S., Hu, Z.-H., Moskop, A., Ahmed, S., Bilal Abid, M., Badar, T., Bredeson, C., Brown, V., Cairo, M. S., Díaz, M., Dholaria, B., Ganguly, S., Grover, N. S., Hanna, R., Hematti, P., Kohorst, M. A., Lazarus, H., … Perales, M.-A. (2021). Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Blood, 138(Supplement 1), 3880–3880. https://doi.org/10.1182/blood-2021-148652

Walters, M. C., Tisdale, J. F., Mapara, M. Y., Krishnamurti, L., Kwiatkowski, J. L., Aygun, B., Kasow, K. A., Rifkin-Zenenberg, S., Jaroscak, J., Garbinsky, D., Chirila, C., Gallagher, M. E., Zhang, X., Ho, P.-R., Thompson, A. A., & Kanter, J. (2021). Sustained Improvements in Patient-Reported Quality of Life up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy. Blood, 138(Supplement 1), 7–7. https://doi.org/10.1182/blood-2021-146905

Tisdale, J. F., Thompson, A. A., Mapara, M. Y., Kwiatkowski, J. L., Krishnamurti, L., Aygun, B., Kasow, K. A., Rifkin-Zenenberg, S., Schmidt, M., Pierciey, F. J., Whitney, D., Rogers, C., Nnamani, M., Foos, M., Miller, A., Zhang, X., Lynch, J., Walters, M. C., Kanter, J., & Bonner, M. (2021). Polyclonality Strongly Correlates with Biological Outcomes and Is Significantly Increased Following Improvements to the Phase 1/2 HGB-206 Protocol and Manufacturing of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy (GT). Blood, 138(Supplement 1), 561–561. https://doi.org/10.1182/blood-2021-147760

Hill, B. T., Roth, C. J., Kositsky, R., Dave, T., Love, C., McKinney, M., Galal, A., Neff, J. L., Mian, A., Kendall, E., Ondrejka, S. L., Chiaramonte, M., Bhagat, G., Ofori, K., Reshef, R., Kovach, A. E., Sethi, T., Mason, E. F., Bhaskar, S., … Dave, S. S. (2021). Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. Blood, 138(Supplement 1), 165–165. https://doi.org/10.1182/blood-2021-145764

Aschauer, C., Jelencsics, K., Hu, K., Heinzel, A., Gregorich, M. G., Vetter, J., Schaller, S., Winkler, S. M., Weinberger, J., Pimenov, L., Gualdoni, G. A., Eder, M., Kainz, A., Troescher, A. R., Regele, H., Reindl-Schwaighofer, R., Wekerle, T., Huppa, J. B., Sykes, M., & Oberbauer, R. (2021). Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.750005

Strazza, M., Bukhari, S., Tocheva, A. S., & Mor, A. (2021). PD‐1‐induced proliferating T cells exhibit a distinct transcriptional signature. Immunology, 164(3), 555–568. Portico. https://doi.org/10.1111/imm.13388

Soni, M., Migliori, E., Assal, A., Chan, H. T., Ciubotariu, R., Pan, J. B., Cicero, K., Pereira, M., Mapara, M. Y., & Muranski, P. (2021). Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection. Cytotherapy, 23(11), 980–984. https://doi.org/10.1016/j.jcyt.2021.05.005

Oran, B., Ahn, K. W., Fretham, C., Beitinjaneh, A., Bashey, A., Pawarode, A., Wirk, B., Scott, B. L., Savani, B. N., Bredeson, C., Weisdorf, D., Marks, D. I., Rizzieri, D., Copelan, E., Hildebrandt, G. C., Hale, G. A., Murthy, H. S., Lazarus, H. M., Cerny, J., … Saber, W. (2021). Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplantation and Cellular Therapy, 27(11), 921.e1-921.e10. https://doi.org/10.1016/j.jtct.2021.08.007

Takeuchi, K., Ariyoshi, Y., Shimizu, A., Okumura, Y., Cara‐Fuentes, G., Garcia, G. E., Pomposelli, T., Watanabe, H., Boyd, L., Ekanayake‐Alper, D. K., Amarnath, D., Sykes, M., Sachs, D. H., Johnson, R. J., & Yamada, K. (2021). Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig‐to‐baboon xenotransplantation. Xenotransplantation, 28(6). Portico. https://doi.org/10.1111/xen.12708

Mantell, B. S., Cordero, H., See, S. B., Clerkin, K. J., Vasilescu, R., Marboe, C. C., Naka, Y., Restaino, S., Colombo, P. C., Addonizio, L. J., Farr, M. A., & Zorn, E. (2021). Transcriptomic heterogeneity of antibody mediated rejection after heart transplant with or without donor specific antibodies. The Journal of Heart and Lung Transplantation, 40(11), 1472–1480. https://doi.org/10.1016/j.healun.2021.06.012

Rausser, S., Trumpff, C., McGill, M. A., Junker, A., Wang, W., Ho, S.-H., Mitchell, A., Karan, K. R., Monk, C., Segerstrom, S. C., Reed, R. G., & Picard, M. (2021). Mitochondrial phenotypes in purified human immune cell subtypes and cell mixtures. ELife, 10. CLOCKSS. https://doi.org/10.7554/elife.70899

Zorn, E., & See, S. B. (2021). Antibody Responses to Minor Histocompatibility Antigens After Solid Organ Transplantation. Transplantation, 106(4), 749–753. https://doi.org/10.1097/tp.0000000000003969

van Besouw, N. M., Rojas, A. M., See, S. B., de Kuiper, R., Dieterich, M., Roelen, D. L., Clahsen-van Groningen, M. C., Hesselink, D. A., Zorn, E., & Baan, C. C. (2021). Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation. Journal of Transplantation, 2021, 1–9. https://doi.org/10.1155/2021/7005080

Pellegrino, B., Tommasi, C., Cursio, O. E., Musolino, A., Migliori, E., De Silva, P., Senevirathne, T. H., Schena, M., Scartozzi, M., Farci, D., Willard-Gallo, K., & Solinas, C. (2021). A review of immune checkpoint blockade in breast cancer. Seminars in Oncology, 48(3), 208–225. https://doi.org/10.1053/j.seminoncol.2021.09.002

Giangreco, N. P., Lebreton, G., Restaino, S., Jane Farr, M., Zorn, E., Colombo, P. C., Patel, J., Levine, R., Truby, L., Soni, R. K., Leprince, P., Kobashigawa, J., Tatonetti, N. P., & Fine, B. M. (2021). Plasma kallikrein predicts primary graft dysfunction after heart transplant. The Journal of Heart and Lung Transplantation, 40(10), 1199–1211. https://doi.org/10.1016/j.healun.2021.07.001

Assal, A., & Mapara, M. Y. (2021). Janus Kinase Inhibitors and Cell Therapy. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.740847

Lerrer, S., Tocheva, A. S., Bukhari, S., Adam, K., & Mor, A. (2021). PD-1-stimulated T cell subsets are transcriptionally and functionally distinct. IScience, 24(9), 103020. https://doi.org/10.1016/j.isci.2021.103020

Ager, C. R., Boda, A., Rajapakshe, K., Lea, S. T., Di Francesco, M. E., Jayaprakash, P., Slay, R. B., Morrow, B., Prasad, R., Dean, M. A., Duffy, C. R., Coarfa, C., Jones, P., & Curran, M. A. (2021). High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege. Journal for ImmunoTherapy of Cancer, 9(8), e003246. https://doi.org/10.1136/jitc-2021-003246

Sferra, S., & Weiner, J. (2021). Novel presentation of perforated diverticulitis at the ligament of Treitz. Surgery, 170(2), e7–e8. https://doi.org/10.1016/j.surg.2021.01.019

Strazza, M., Adam, K., Lerrer, S., Straube, J., Sandigursky, S., Ueberheide, B., & Mor, A. (2021). SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function. Inflammation, 44(4), 1529–1539. https://doi.org/10.1007/s10753-021-01437-8

Waffarn, E. E., Khosravi‐Maharlooei, M., Vecchione, A., Shao, S., Vishwasrao, P., HÖlzl, M. A., Frangaj, K., Sykes, M., & Li, H. W. (2021). Mixed xenogeneic porcine chimerism tolerizes human anti‐pig natural antibody‐producing cells in a humanized mouse model. Xenotransplantation, 28(4). Portico. https://doi.org/10.1111/xen.12691